Shriner Daniel, Rodrigo Allen G, Nickle David C, Mullins James I
Department of Microbiology, University of Washington School of Medicine, Seattle, Washington 98195-8070, USA.
Genetics. 2004 Aug;167(4):1573-83. doi: 10.1534/genetics.103.023382.
Recombinants of preexisting human immunodeficiency virus type 1 (HIV-1) strains are now circulating globally. To increase our understanding of the importance of these recombinants, we assessed recombination within an individual infected from a single source by studying the linkage patterns of the auxiliary genes of HIV-1 subtype B. Maximum-likelihood phylogenetic techniques revealed evidence for recombination from topological incongruence among adjacent genes. Coalescent methods were then used to estimate the in vivo recombination rate. The estimated mean rate of 1.38 x 10(-4) recombination events/adjacent sites/generation is approximately 5.5-fold greater than the reported point mutation rate of 2.5 x 10(-5)/site/generation. Recombination was found to be frequent enough to mask evidence for purifying selection by Tajima's D test. Thus, recombination is a major evolutionary force affecting genetic variation within an HIV-1-infected individual, of the same order of magnitude as point mutational change.
既往存在的人类免疫缺陷病毒1型(HIV-1)毒株的重组体目前正在全球范围内传播。为了加深我们对这些重组体重要性的理解,我们通过研究HIV-1 B亚型辅助基因的连锁模式,评估了单一来源感染个体内的重组情况。最大似然系统发育技术通过相邻基因间拓扑不一致揭示了重组证据。然后采用溯祖方法估计体内重组率。估计的平均重组率为1.38×10⁻⁴重组事件/相邻位点/代,约为报道的点突变率2.5×10⁻⁵/位点/代的5.5倍。发现重组频率足以掩盖通过 Tajima's D 检验进行的纯化选择证据。因此,重组是影响HIV-1感染个体内遗传变异的主要进化力量,其量级与点突变变化相同。